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Received June 2, 2011; accepted July 21, 2011AbstractBackground: The safety and advantages of CO2 laser myringotomy for otitis media with effusion (OME) are well described. The goal of such
treatment is to avoid unnecessary ventilation tube insertion. Comparisons between different age groups treated with this modality are lacking,
and prognostic factors for treatment outcomes are not available.
Methods: We conducted a retrospective cohort study that included 130 children (160 ears) and 96 adults (108 ears) with OME persisting after
conservative antibiotic treatment. In eligible patients, we performed laser myringotomy in the affected ear. Follow-up was scheduled every week
for 1 month and then every month for 6 months. Results for 233 ears were available for analysis; 24 ears were excluded (19 due to cancer, four
due to a cleft palate, and one due to Down syndrome) and 10 patients (11 ears) were lost during follow-up. A logistic regression model was used
for analysis, with success of therapy as the binary outcome.
Results: Adult patients had more unilateral lesions ( p < 0.001) and serous fluid effusions ( p < 0.001) than did the pediatric patients. However,
there was no significant difference in the cure rate (children: 58.1%; adults: 64.7%) and positive culture rate (children: 15.1%; adults: 14.3%)
between patient groups. Three factors were found to be associated with a poor prognosis: multiple occurrences in children ( p < 0.001), mucoid
effusion ( p ¼ 0.04), and a history of ventilation tube use in adults ( p < 0.001). No other variables predicted treatment outcome.
Conclusion: Our findings suggest that CO2 laser myringotomy is a useful treatment modality for OME in children and adults, except for children
with multiple occurrences and in adults with mucoid effusions and a history of ventilation tube use.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Otitis media with effusion (OME) is one of the most
common infectious diseases worldwide, both in children and
adults. Treatment methods include watchful waiting, antibiotic
treatment, and surgical intervention. Ventilation tube insertion
(VTI) for OME persisting for more than 3 months is a well-
accepted treatment method and is one of the most frequently
performed operations in children. In the United States, yearly
expenditures for this disease exceed $5 billion,1,2 comprising* Corresponding author. Dr. An-Suey Shiao, Division of Otology, Depart-
ment of Otorhinolaryngology-Head and Neck Surgery, Taipei Veterans
General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, ROC.
E-mail address: asshiao@vghtpe.gov.tw (A.-S. Shiao).
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doi:10.1016/j.jcma.2011.10.001more than 24 million doctor visits. Although watchful waiting
for 3 months is recommended, concern has been raised
regarding a child’s quality of life and language development
during this time. Conventional myringotomy heals after 1e2
days, which is too short of a time to achieve a therapeutic effect.
Armstrong and Armstrong, who reintroduced the ventilation
tube in the 1950s, regarded a 3-week period of transtympanic
ventilation as adequate for OME.3
Although inserting a ventilation tube is a minor procedure,
a major disadvantage associated therewith is the need for
general anesthesia in children and complications such as
chronic perforation, chronic tympanic granuloma, tympanic
membrane atrophy, atelectasis, cholesteatoma, and chronic
discharge.4e6hinese Medical Association. All rights reserved.
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first introduced by Goode in 1982,7 and coupled to a handheld
otoscope by DeRowe and colleagues in 19948; a flashscanner
connected to the otoscope has subsequently made LAT a safer
technique.9 The safety and advantages of CO2 laser myr-
ingotomy have been well described.10 This treatment allows
intermediate-duration middle-ear ventilation (16.35 days)11
and can be performed under topical anesthesia in an office
setting.12,13
However, the indications for this treatment and its effec-
tiveness in different age groups are not yet known. Therefore,
the purpose of this study was to evaluate characteristics of
OME treated with CO2 laser myringotomy in children and
adults. We reveal differences between age groups and examine
prognostic factors associated with treatment outcome.
2. Methods2.1. PatientsChildren (aged  14 years) and adults (aged  15 years)
with OME of varying duration were included in this study. CO2
laser myringotomy was indicated when conservative treatment,
i.e., oral antibiotic therapy for more than 2 weeks, had failed.
Patients were either referred to us from local medical
clinics or came to our clinic ab initio. We verified their previous
antibiotic treatment history and prescribed a 2-week course of
oral antibiotics for those who had not used antibiotics for this
episode of OME. Prior to enrollment, we explained the treat-
ment choices to the patient, or parents of the patients, which
included watchful waiting, laser myringotomy, and VTI (for
OME lasting 3 months or longer, or persistent OME in children
at risk). The final choice was made by the patient (or the parents
of the patient). Patients who chose laser myringotomy were
enrolled in this study.
OME was defined as an accumulation of effusion in the
middle ear without signs of acute inflammation. The diagnosis
was made by an otolaryngologist with video telescopy as the
mainstay of conformation14 in combination with a type B
tympanogram or pure-tone audiometry.
A total of 130 children (160 ears) and 96 adults (108 ears)
with OME were enrolled in this trial in the Department of
Otorhinolaryngology of the Taipei Veterans General Hospital
from January 2006 to December 2009. During the analysis, 24
ears were excluded (19 due to cancer, four due to a cleft
palate, and one due to Down syndrome). Ten patients (11 ears)
were lost during follow-up. Therefore, assessment of outcomes
for 233 ears was possible at the conclusion of the study.2.2. InterventionsBefore CO2 laser myringotomy, patient demographic data
were collected, and tympanometry was performed in all
patients. Sound-threshold audiometry was recorded in children
over 4 years old, and noise or play audiometry was recorded in
younger children. Audiometry was repeated postoperatively.
Laser myringotomy was performed using a CO2 flashscannerlaser (OtoLAM; ESC/Sharplan, Tel Aviv, Israel), which
creates a round perforation in the tympanic membrane. Patients
underwent the procedure in an office setting with the use of 10%
lidocaine (Xylocaine) local anesthesia for 30 minutes. The
anesthetic solution was infiltrated directly into the ear canal with
a 3-mL syringe with the patient lying on the other side. Circular
perforations were created in all affected ears in the lower ante-
rior or lower posterior quadrant according to each patient’s
anatomic structure, with a power of 15 W, single pulse duration
of 200 milliseconds, and a scanned area of 1.9 mm in diameter.
After creating the fenestration, aspiration of fluid from the
middle ear was performed under microscopic control, and the
fluid was sent for culturing with a specially designed suction
culture bottle. No postoperative eardrops were prescribed.2.3. Informed consentAdult patients and parents of participating children gave
written informed consent before enrollment. An otolaryngol-
ogist explained the potential risks and benefits of the surgical
intervention. The medical ethical review committees of our
hospitals approved the study protocol.2.4. Main outcome measuresPostoperative perforation healing time and eardrum condition
were evaluated by outpatient clinic examination weekly for 1
month, and then monthly for another 5 months. Resolution of
disease was defined as both normal video telescopy findings and
a type-A tympanogram.Resolution, persistence, or recurrence of
disease was documented at the 6-month follow-up examination.
Additional data collected included patient age, sex, disease
duration, underlying disease, past ear interventions, operation
date, lesion side, myringotomy location, type of effusion,
perforation healing date, disease status, pain score, postoperative
tympanic membrane condition, and pre- and postoperative
tympanogram and tympanic characteristics.
We define treatment success (cured of disease) as no
evidence of fluid after the perforation had healed and no OME
recurrence for 3 months. We classified OME recurrence within
3 months as treatment failure. Multiple occurrences were
defined as ears that received more than one intervention with
a normal interval longer than 3 months.2.5. Statistical analysisWe first investigated the association between age group and
the risk factors listed in Table 1. The Chi-square test was used
for categorical risk factors. Two-tailed t test was used for
continuous variables.
Secondly, the effect of potential prognostic factors was
evaluated using the mixed logit model. In the mixed logit
model, Y ¼ 1 was defined as an uncured status after under-
going CO2 laser myringotomy. Repeated measurements were
collected for a single patient; thus, the random intercept model
was used to assess the effect of prognostic factors on
outcomes. Each risk factor was included in the univariate logit
Table 1
Demographic data.
Children Adults p value
Total patient number 100 63
Total ear number 148 85
n % n %
Age (yrs)a 7.70 (1e14) 56.42 (15e90)
Sex
Women 58 39.2 51 60.0 0.002
Men 90 60.8 34 40.0
Underlying disease
No disease 107 72.3 65 76.5 0.002
Allergic rhinitis and sinusitis or adenoiditis 36 24.3 9 10.6
Mastoiditis and previous tympanoplasty 5 3.4 11 12.9
Mean disease duration (wks)b 8.18 (6.75) 6.52 (7.67) 0.215
Uni or bilateral
Unilateral 61 41.2 68 80.0 < 0.001
Bilateral 87 58.8 17 20.0
Season
Winter 38 25.7 24 28.2 0.820
Spring 56 37.8 34 40.0
Summer 28 18.9 12 14.1
Autumn 26 17.6 15 17.6
Fluid appearance
Serous 51 34.5 66 80.5 < 0.001
Glue-like 49 33.1 10 12.2
Others 48 32.4 6 7.3
Multiple occurrence
No 123 83.1 64 75.3 0.149
Yes 25 16.9 21 24.7
VTI history
No 123 83.7 71 83.5 0.977
Yes 24 16.3 14 16.5
Culture result
Negative 107 82.3 60 82.2 0.918
Positive 19 14.6 10 13.7
No culture data 4 3.1 3 4.1
Treatment result
Not cured 62 41.9 30 35.3 0.321
Cured 86 58.1 55 64.7
VTI ¼ ventilation tube insertion.
a The mean (range) of age is shown.
b The mean (SD) of mean disease duration is shown.
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outcomes. However, when a specific category of a factor is
rare, the estimate is unreliable and inefficient. In this situation,
we calculated the odds ratio based on the observed odds, and
we derived the p value using the two-tailed Fisher Exact test.
In multivariate logistic regression analysis, two variables with
a p value less than 0.05 in a univariate logit mixed model (VTI
history, multiple occurrence) were accepted and combined
with two variables that might have clinical significance and
confounding effect (sex and disease duration) as covariables toestimate of the predictive effect of treatment failure in Table 3.
All statistical analyses were performed using STATA 10.1
(StataCorp, College Station, TX USA).
3. Results
Demographic data are shown in Table 1. Variables that
showed no significant differences between age groups included
disease duration, the season in which the operation was per-
formed, multiple occurrences, VTI history, and positive culture
Table 2
Odds ratio of each factor in a univariate mixed logic model.
Children Adults
Cured Uncured Cured Uncured
n % n % OR p value n % n % OR p value
Sex:
Women
35 40.7 23 37.1 d 33 60.0 18 60.0 d
Men 51 59.3 39 62.9 2.048 0.493 22 40.0 12 40.0 1.228 0.829
Underlying disease:
No disease
64 74.4 43 69.4 d 44 80.0 21 70.0 d
Allergic rhinitis and sinusitis or adenoiditis 21 24.4 15 24.2 1.063 0.99b 5 9.1 4 13.3 3.788 0.424
Mastoiditis and previous tympanoplasty 1 1.2 4 6.5 5.953 0.15b 6 10.9 5 16.7 1.996 0.540
Mean disease duration (wks)a 9.64 (8.40) 7.03 (4.85) 1.170 0.055 5.81 (5.17) 6.91 (8.79) 0.933 0.319
Unilateral 38 44.2 23 37.1 d 43 78.2 25 83.3 d
Bilateral 48 55.8 39 62.9 4.241 0.162 12 21.8 5 16.7 0.620 0.706
Season:
Winter
26 30.2 12 19.4 d 12 21.8 12 40.0 d
Spring 30 34.9 26 41.9 2.342 0.442 27 49.1 7 23.3 0.049 0.053
Summer 16 18.6 12 19.4 1.206 0.886 8 14.5 4 13.3 0.097 0.188
Autumn 14 16.3 12 19.4 2.907 0.416 8 14.5 7 23.3 0.633 0.753
Fluid appearance: Serous 29 33.7 22 35.5 d 43 78.2 23 76.7 d
Glue-like 31 36.0 18 29.0 0.691 0.702 3 5.5 7 23.3 4.362 0.044b
Others 26 30.2 22 35.5 1.286 0.799 6 10.9 d d 0.156 0.414b
Multiple occurrence
No
82 95.3 41 66.1 d 44 80.0 20 66.7 d
Yes 4 4.7 21 33.9 10.500 < 0.001b 11 20.0 10 33.3 3.112 0.321
VTI history
No
77 89.5 46 75.4 d 52 94.5 19 63.3 d
Yes 9 10.5 15 24.6 4.006 0.237 3 5.5 11 36.7 10.035 < 0.001b
Culture result
Negative
59 80.8 48 90.6 d 39 86.7 21 84.0 d
Positive 14 19.2 5 9.4 0.124 0.115 6 13.3 4 16.0 1.000 0.999
VTI ¼ ventilation tube insertion.
a The mean (SD) of mean disease duration (wks) is shown.
b The p value is based on Fisher’s Exact test (two-sided).
32 C.-W. Chang et al. / Journal of the Chinese Medical Association 75 (2012) 29e35rate. In contrast, children had a higher percentage of male
patients, mucoid fluid, involvement of both ears, and history of
allergic rhinitis and/or sinusitis. Treatment results did not differ
significantly between the adult and child patient groups.
The cure rate was 60.5% (141/233) in all ears, 58.1% in
children and 64.7% in adults. Seven patients had multiple
occurrences, with visit intervals ranging from 4 to 12 months,
at an average of 5.1 months. We obtained a culture report forTable 3
Odds ratio of each factor in a multiple mixed logic model.
Children Adults
OR p value OR p value
Sex
Women
d d
Men 0.568 0.544 1.029 0.986
Mean disease duration (wks) 1.137 0.123 0.937 0.405
Multiple occurrence
No
d d
Yes 85.594 0.013 2.670 0.582
VTI history
No
d d
Yes 11.054 0.084 650.448 0.018
VTI ¼ ventilation tube insertion.206 of 244 ears; the positive rate was 15.1% (19/132) in
children and 14.3% (10/74) in adults.
Univariate logistic regression analysis (Table 2) and multi-
variate logistic regression (Table 3) revealed three predictors of
treatment failure. In the adult group, significant predictors of
treatment failure were mucoid effusion ( p ¼ 0.04) and
a history of VTI ( p < 0.001). In children, multiple occurrences
( p < 0.001) were predictive of a poor prognosis.3.1. Complications during follow-upAfter LAT, only one ear of a boy aged 5 years developed
chronic otitis media from OME. This child had allergic rhinitis,
but he did not have a history of VTI. Culture showed no
bacterial growth initially; however, pus formation was noted
during follow-up. No other complications or postoperative
sensorineural hearing loss were observed in any patient.
4. Discussion
Our study confirms the safety of laser myringotomy in both
children and adults.10,13,15 We also showed an equivalent
success rate in both patient groups despite a few demographic
differences. Further, we determined predictors of poor treatment
33C.-W. Chang et al. / Journal of the Chinese Medical Association 75 (2012) 29e35outcome in each patient group, which may be used to identify
appropriate candidates for LAT.
OME in children and adults has previously been assumed to
constitute different conditions.16 OME epidemiology, disease
course, risk factors, and management have been widely studied
in children.17,18 However, little is known about adult-onset
OME.19 Based on the concept that the etiology of OME is
multifactorial, many different factors are implicated in the
pathophysiology of this disease.20 Therefore, the impact of
different prognostic factors may also differ between age groups.
In the present study, we compared possible prognostic
factors for OME between children and adults and examined
potential demographic differences between these patient
groups. The child group contained a greater number of male
patients and had a greater incidence of allergic rhinitis and/or
sinusitis history, involvement of both ears, and mucoid effu-
sion. Variables that did not differ significantly between adult
and child patients included mean disease duration, the season
in which the operation was performed, the percentage of
multiple occurrences, and previous VTI history.
Possible explanations for the greater number of unilateral
lesions observed in adults are, first, natural prevalence and,
second, the adult patient’s alertness to a unilateral lesion, which
is more dependable than parental suspicion in children.21
However, selection bias may be partly responsible for this
difference, because laser myringotomy is generally preferred to
VTI for unilateral lesions. On the other hand, the higher
prevalence of serous middle ear effusion may also be a char-
acteristic finding in adult patients, as, unexpectedly, 10 ears
with glue-like effusion in adults were observed in unilaterally
involved ears, rather than in cases where both ears were
involved. To understand the pathophysiology of adult-onset
OME, Kariya and colleagues examined inflammatory cyto-
kine expression in adult-onset OME22 and Chung and others
analyzed the composition of mucin in mucoid middle ear
effusions.23 Yung and colleagues concluded that the paranasal
sinusitis plays a role in adult-onset OME.19 Zhao and others
found that interleukin-10 and transforming growth factor-b1,
as immunoregulatory mediators, participate in the inflamma-
tory response in chronic OME in adults.24 In our study, mucoid
effusion was significantly associated with treatment failure in
adults, but not in children; a similar trend for OME recurrence
after VTI dropping was observed in a previous study.6 There-
fore, a difference in the pathogenesis of OME may exist not
only between age groups but also between fluid types. It is
difficult to predict the type of effusion fluid involved in OME
before myringotomy. Therefore, estimating the type of effusion
involved based on eardrum examination may provide a suitable
parameter for determining the choice of treatment in the future.
The advantages associated with CO2 laser myringotomy
have been widely studied. However, most previous publications
have focused on children,7,8,10e12,25e29 and only a few studies
have examined both children and adults.13,30 Further, there is no
general agreement about the indications for this treatment and
prognostic factors. Significant predictors of LAT outcome in
children have been shown to include allergic rhinitis, sinusitis,
exposure to smoking, disease duration, eardrum condition,mucous fluid, and adenoidectomy.10,13,26,29 However, little is
known about prognostic factors for LAT in adult-onset OME.30
In our series, we confirmed that several variables are not related
to treatment outcome, as shown in previous publications,
namely, age, sex, and season. However, we also found that
disease duration and history of allergy and/or sinusitis had no
impact on treatment efficacy in our study, although these factors
have previously been described as being predictive of outcome.
Koopman and colleagues10 found no significant effect of
a history of inserted tubes on the treatment outcome in children.
In our series, only 12 of the 38 ears with a history of VTI were
cured. After a multivariate logistic regression analysis, VTI
history was strongly associated with treatment failure in adults,
but not in children. This finding is compatible with the report of
Koopman and others.10 A possible reason for the predictive
value of VTI history in adults may be that Eustachian tube
dysfunction plays a major role in OME in adults, but not in
children, which implies that CO2 laser myringotomy is less
effective in patients with a history of VTI because this proce-
dure cannot solve the underlying structural problem. On the
other hand, in children with a history of VTI, laser treatment
should not be contraindicated because their Eustachian tube
function improves during development. Therefore, the CO2
laser may be particularly useful for children, rather than adults,
to avoid the additional insertion of a ventilation tube.
Multiple OME occurrences in children, i.e., more than one
intervention with a normal interval (4e12 months in our
study), were found to be another significant prognostic factor.
A possible explanation for this finding is that children with
Eustachian tube dysfunction are vulnerable to OME recur-
rence, which is compatible with the report of Hogan and
colleagues concerning children younger than 3 years.31 The
authors concluded that children who are susceptible to OME
tended to have a greater number of separate episodes, rather
than an increased overall duration. Such children are primarily
distinguished by the likelihood with which they might acquire
the disease. Although our patients with multiple occurrences
recognized that LAT is helpful for a good hearing interval, we
may suggest VTI due to a reduced chance of avoiding it.
OME is not only a disease resulting from Eustachian tube
dysfunction, but it is also an infectious disease. The conven-
tional culture rate ranges from 15% to 25%,32,33 which is
compatible with our results of 14.4% in children and 13.7% in
adults. Many reports have examined biofilms and isolation of
the bacterium Alloiococcus otitidis, which have been linked to
the development of OME.34e36 Even when the culture is
negative, a metabolically active pathogen may exist,32 and
evidence indicates a role of this pathogenic bacterium in
resistance to antibiotics such as beta-lactamase and erythro-
mycin in children with OME.37 Therefore, a negative culture is
no longer a favorable finding, and further investigation is
needed to clarify the possible efficacy of simultaneous laser
myringotomy treatment and pathogen eradication.
Although underlying tympanoplasty or mastoiditis was not
significantly associated with treatment outcome in our study,
this finding may be due to the small number of cases included.
In our cohort, there were only two ears with a history of
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findings in those patients appear to be less than favorable, with
only seven cures in 16 ears. Chronic inflammation in child-
hood may lead to hypopneumatization of the mastoid, which
may result in poor OME outcomes in adults receiving
nonsurgical treatment.38 Tympanoplasty changes the normal
eardrum structure, similar to the impact of a thickening of the
eardrum.27 Thus, in our opinion, patients with a history of
tympanoplasty or mastoiditis are not good candidates for LAT.
Some authors have concluded that it is risky to perform
LAT under local anesthesia in children younger than 6 years.
In our series, which included 46 patients younger than 6 years
[3-year-olds (n ¼ 8), 4-year-olds (n ¼ 15), and 5-year-olds
(n ¼ 23)], the cure rate was 83.3%, and only one patient
experienced complication of chronic otitis media. Therefore,
we believe that young age is not a contraindication to LAT.
Patients were enrolled in our study following referral by
a local clinic or the choice of the patient (or parents). No
randomized controlled trial comparing watchful waiting and
CO2 laser treatment is currently available. We decided against
randomization in our study for ethical reasons. However, due to
this lack of randomization, a selection bias may have existed.
Therefore, we used a multiple variable logistic regression to
assess our results. Further, due to the lack of a control group,
we could only compare our findings with the natural course of
OME.31 However, we believe that it would be unethical to
randomize patients to laser myringotomy in one ear and not the
other, or to randomize some patients to treatment and others to
watchful waiting. Interestingly, our study included 18 patients
with bilateral lesions who received surgery on only one side.
The reason for this discrepancy was inadequate cooperation of
the child or spontaneous resolution of OME in the other ear
when visiting the clinic for the second surgery. Additional case
accumulation may answer the question.
In conclusion, we found that the pathogenesis of OME in
children and adults differed, but that the efficacy of LAT was
equivalent in both patient groups. Three predictors of treat-
ment outcome were identified in our study, which may help
guide the selection of treatment in patients with OME. We
believe that CO2 laser myringotomy may be used successfully
in adults and children with OME. Contraindications to this
treatment include multiple occurrences in children and mucoid
effusion and a history of VTI in adults.References
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